Following these proceedings, Bernstein downgraded its Genmab ADR [GMAB] rating to an Underperform from a a Mkt perform in a research note published recently. A number of analysts have revised their coverage, including William Blair’s analysts, who increased its forecast for the stock in mid March from “a Mkt perform” to “an Outperform”. Leerink Partners also remained covering GMAB and has increased its forecast on February 13, 2025 with a “an Outperform” recommendation from previously “Market perform” rating. Redburn Atlantic started covering the stock on October 08, 2024. It rated GMAB as “a Buy”.
Price Performance Review of GMAB
On Tuesday, Genmab ADR [NASDAQ:GMAB] saw its stock jump 1.00% to $20.27. Over the last five days, the stock has gained 4.92%. Genmab ADR shares have fallen nearly -2.87% since the year began. Nevertheless, the stocks have fallen -28.45% over the past one year. While a 52-week high of $30.41 was reached on 03/07/25, a 52-week low of $17.24 was recorded on 04/09/25. SMA at 50 days reached $20.54, while 200 days put it at $22.93.
Levels Of Support And Resistance For GMAB Stock
The 24-hour chart illustrates a support level at 19.87, which if violated will result in even more drops to 19.47. On the upside, there is a resistance level at 20.48. A further resistance level may holdings at 20.68. The Relative Strength Index (RSI) on the 14-day chart is 55.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.05, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 0.49%. Stochastics %K at 97.22% indicates the stock is a selling.
How much short interest is there in Genmab ADR?
A steep rise in short interest was recorded in Genmab ADR stocks on 2025-03-31, dropping by -0.16 million shares to a total of 2.15 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 2.31 million shares. There was a decline of -7.24%, which implies that there is a negative sentiment for the stock.
